Form 8-K - Current report:
SEC Accession No. 0001826667-25-000018
Filing Date
2025-02-19
Accepted
2025-02-18 17:31:50
Documents
14
Period of Report
2025-02-18
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K tlsi-20250218.htm   iXBRL 8-K 32648
  Complete submission text file 0001826667-25-000018.txt   200574

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlsi-20250218.xsd EX-101.SCH 2193
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tlsi-20250218_def.xml EX-101.DEF 15975
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlsi-20250218_lab.xml EX-101.LAB 27896
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlsi-20250218_pre.xml EX-101.PRE 16713
16 EXTRACTED XBRL INSTANCE DOCUMENT tlsi-20250218_htm.xml XML 4178
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Filer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39813 | Film No.: 25636269
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)